Prices are updated after-hours
Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Fda    source : Ir.biolinerx.com    save search
BioLineRx Announces U.S. FDA Acceptance of New Drug Application for APHEXDA® (motixafortide) in Stem Cell Mobilization
Published: 2022-11-10 (Crawled : 12:00) - ir.biolinerx.com
BLRX | $0.6401 42K twitter stocktwits trandingview |
Health Technology
 | | O: -4.75% H: 11.5% C: -20.21%
aphexda fda drug application
BioLineRx Announces Submission of New Drug Application (NDA) to FDA for Motixafortide in Stem Cell Mobilization
Published: 2022-09-12 (Crawled : 11:00) - ir.biolinerx.com
BLRX | $0.6401 42K twitter stocktwits trandingview |
Health Technology
 | | O: -3.3% H: 1.7% C: -6.82%
fda drug application submission
Gainers vs Losers
77% 23%

Top 10 Gainers
AGBA | News | $1.22 205.0% 86M twitter stocktwits trandingview |
Finance
EGOX | $0.054 50.0% 290M twitter stocktwits trandingview |

CHRO | $1.66 35.51% 70K twitter stocktwits trandingview |
n/a
INDO | $5.43 33.09% 10M twitter stocktwits trandingview |
Energy Minerals
NVFY | $2.71 28.44% 31M twitter stocktwits trandingview |
Consumer Durables
ZCMD | $1.86 28.28% 29M twitter stocktwits trandingview |
Commercial Services
RWOD | $10.08 26.05% 5.6M twitter stocktwits trandingview |
n/a
HUSA 4 | $2.07 23.95% 2.1M twitter stocktwits trandingview |
Energy Minerals
TPET | $0.4001 22.02% 35M twitter stocktwits trandingview |
n/a
SRFM 4 | $0.6 21.29% 850K twitter stocktwits trandingview |
n/a
Your saved searches
Save your searches and get alerts when important news are released.